Bellwether Investment Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-10,330
Closed -$749K 61
2017
Q2
$749K Sell
10,330
-32
-0.3% -$2.15K 3.47% 3
2017
Q1
$675K Sell
10,362
-2,914
-22% -$183K 1.78% 4
2016
Q4
$831K Buy
+13,276
New +$810K 0.75% 20
2016
Q2
$932K Buy
+15,062
New +$918K 1.02% 16

Other funds holding ABBV

Bellwether Investment Group's ABBV Position: Q3 2017 in Review

Bellwether Investment Group sold out of AbbVie (ABBV) in Q3 2017, closing a stake of 10,330 shares — an estimated $749K sold.

Bellwether Investment Group first reported a position in ABBV in Q2 2016 and held it in 4 quarters. The position peaked at $932K in Q2 2016. 1,798 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.

  • Bellwether Investment Group reported no remaining AbbVie position as of Q3 2017 after selling out during the quarter.
  • Bellwether Investment Group sold 10,330 AbbVie shares in Q3 2017, an estimated $749K.
  • Bellwether Investment Group first reported a position in AbbVie in Q2 2016 and held it in 4 quarters.
  • Bellwether Investment Group's AbbVie position peaked at $932K in Q2 2016.
  • 1,798 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.

Based on Bellwether Investment Group's 13F filing for Q3 2017, filed 13 Nov 2017.